z-logo
open-access-imgOpen Access
Magnesium supplementation prevents experimental chronic cyclosporine a nephrotoxicity via renin-angiotensin system independent mechanism.
Author(s) -
Tomio Asai,
Tatsuya Nakatani,
Shinya Yamanaka,
Satoshi Tamada,
Toshifumi Kishimoto,
Koichiro Tashiro,
Takafumi Nakao,
Mitsu Okamura,
Shokei Kim,
Hiroshi Itoh,
Katsuyuki Miura
Publication year - 2002
Publication title -
transplantation
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-200209270-00009
Subject(s) - endocrinology , medicine , fibrosis , glomerulosclerosis , nephropathy , kidney , angiotensin ii , renal function , monocyte , inflammation , nephrotoxicity , pharmacology , chemistry , receptor , proteinuria , diabetes mellitus
We have previously shown that correction of hypomagnesemia by magnesium (Mg) supplementation ameliorates chronic cyclosporine A (CsA) nephropathy via inhibiting gene expression of fibrogenic molecules. Experiments were conducted to further elucidate upstream mechanism of the beneficial effects upon CsA nephrotoxicity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here